Patents by Inventor Daniel C Howey

Daniel C Howey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating vascular disorders
    Patent number: 6426071
    Abstract: A method of treatment for patients with vascular occlusion and thromboembolic disorders including the acquired disease state of thrombotic stroke, by administering activated protein C. The administration of aPC provides a highly selective therapeutic agent with a low potential for causing bleeding complications. The administration of aPC is beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: July 30, 2002
    Assignee: Eli Lilly and Company
    Inventors: Brian W. Grinnell, Daniel C Howey, Charles V Jackson
  • Methods for treating vascular disorders
    Publication number: 20010036456
    Abstract: A method of treatment for patients with vascular occlusion and thromboembolic disorders including the acquired disease state of thrombotic stroke, by administering activated protein C. The administration of aPC provides a highly selective therapeutic agent with a low potential for causing bleeding complications. The administration of aPC is beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke.
    Type: Application
    Filed: June 8, 2001
    Publication date: November 1, 2001
    Inventors: Brian W. Grinnell, Daniel C. Howey, Charles V. Jackson
  • Methods for treating vascular disorders using activated protein C
    Patent number: 6268337
    Abstract: A method of treatment for patients with vascular occlusion and thromboembolic disorders including the acquired disease state of thrombotic stroke, by administering activated protein C. The administration of aPC provides a highly selective therapeutic agent with a low potential for causing bleeding complications. The administration of aPC is beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: July 31, 2001
    Assignee: Eli Lilly and Company
    Inventors: Brian W. Grinnell, Daniel C Howey, Charles V Jackson
  • Methods for treating vascular disorders using activated protein C
    Patent number: 6037322
    Abstract: A method of treatment for patients with vascular occlusion and thromboembolic disorders including the acquired disease state of thrombotic stroke, by administering activated protein C. The administration of aPC provides a highly selective therapeutic agent with a low potential for causing bleeding complications. The administration of aPC is beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: March 14, 2000
    Assignee: Eli Lilly and Company
    Inventors: Brian W. Grinnell, Daniel C Howey, Charles V Jackson